Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
2,203 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | $3.10B | $70.65 | −17.13% | +19.85% |
| ALMS | Alumis Inc. | Healthcare | $3.06B | $23.62 | −24.66% | −12.62% |
| BIOA-B.ST | BioArctic AB (publ) | Healthcare | $3.00B | 345.00 SEK | −5.32% | +6.35% |
| ASKER.ST | Asker Healthcare Group AB (publ) | Healthcare | $2.99B | 74.70 SEK | −29.18% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| −7.15% |
| HYPE3.SA | Hypera S.A. | Healthcare | $2.98B | 22.01 BRL | −20.80% | +2.66% |
| AVAH | Aveanna Healthcare Holdings Inc. | Healthcare | $2.97B | $13.62 | −2.58% | +37.71% |
| ZLAB | Zai Lab Limited | Healthcare | $2.92B | $26.03 | −26.57% | +39.80% |
| BKD | Brookdale Senior Living Inc. | Healthcare | $2.91B | $12.20 | −28.61% | −20.62% |
| ALHC | Alignment Healthcare, Inc. | Healthcare | $2.88B | $13.90 | −44.67% | −24.58% |
| ACHC | Acadia Healthcare Company, Inc. | Healthcare | $2.85B | $30.58 | −14.65% | −6.45% |
| B72.DE | AtaiBeckley Inc. | Healthcare | $2.79B | 6.45 EUR | −16.23% | +2.38% |
| SLS | SELLAS Life Sciences Group, Inc. | Healthcare | $2.77B | $13.73 | −13.54% | +36.08% |
| NRIX | Nurix Therapeutics, Inc. | Healthcare | $2.77B | $26.71 | −5.38% | +10.60% |
| 9989.T | Sundrug Co.,Ltd. | Healthcare | $2.76B | 3,715.00 JPY | −22.26% | −6.47% |
| VRDN | Viridian Therapeutics, Inc. | Healthcare | $2.75B | $24.26 | −29.25% | +24.35% |
| ATAI | AtaiBeckley Inc. | Healthcare | $2.74B | $7.39 | −0.81% | +2.92% |
| RGC | Regencell Bioscience Holdings Limited | Healthcare | $2.72B | $5.50 | −92.03% | −7.87% |
| PRVA | Privia Health Group, Inc. | Healthcare | $2.71B | $21.07 | −26.89% | −15.14% |
| AMBU-B.CO | Ambu A/S | Healthcare | $2.69B | 78.40 DKK | −29.87% | +8.59% |
| WGS | GeneDx Holdings Corp. | Healthcare | $2.69B | $90.29 | −47.16% | +45.90% |
| AXGN | AxoGen, Inc. Common Stock | Healthcare | $2.68B | $51.58 | −0.79% | +25.35% |
| VERA | Vera Therapeutics, Inc. | Healthcare | $2.65B | $36.82 | −34.31% | +10.50% |
| PGEN | Precigen, Inc. | Healthcare | $2.65B | $7.42 | −3.82% | +34.18% |
| CDNA | CareDx, Inc. | Healthcare | $2.64B | $50.96 | −0.32% | +42.55% |
| SUPN | Supernus Pharmaceuticals, Inc. | Healthcare | $2.61B | $44.88 | −24.80% | −5.97% |
| RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | $2.61B | $26.44 | −33.72% | +1.77% |
| EBO.AX | EBOS Group Limited | Healthcare | $2.60B | 17.51 AUD | −51.94% | −7.26% |
| PHVS | Pharvaris N.V. | Healthcare | $2.60B | $37.00 | −2.96% | +9.97% |
| BHVN | Biohaven Ltd. | Healthcare | $2.56B | $16.95 | −8.70% | +23.09% |
| TRVI | Trevi Therapeutics, Inc. | Healthcare | $2.55B | $17.92 | −11.37% | −2.77% |
| BV3.DE | Bavarian Nordic A/S | Healthcare | $2.55B | 29.26 EUR | 0.00% | +23.46% |
| EMEIS.PA | emeis Société anonyme | Healthcare | $2.55B | 13.80 EUR | −14.76% | −0.86% |
| NEOG | Neogen Corporation | Healthcare | $2.54B | $11.70 | −8.95% | +27.31% |
| 2784.T | Alfresa Holdings Corporation | Healthcare | $2.53B | 2,294.00 JPY | −14.58% | −6.65% |
| RAPP | Rapport Therapeutics, Inc. | Healthcare | $2.52B | $52.50 | −0.62% | +25.12% |
| NKTR | Nektar Therapeutics | Healthcare | $2.52B | $73.77 | −32.32% | +4.24% |
| BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | $2.51B | $9.83 | −12.39% | +0.92% |
| CURA.TO | Curaleaf Holdings, Inc. | Healthcare | $2.51B | 13.16 CAD | −22.22% | +8.58% |
| BAVA.CO | Bavarian Nordic A/S | Healthcare | $2.51B | 218.20 DKK | −10.46% | +23.42% |
| KOD | Kodiak Sciences Inc. | Healthcare | $2.48B | $39.33 | −17.79% | −2.38% |
| PBH | Prestige Consumer Healthcare Inc. | Healthcare | $2.47B | $52.15 | −26.62% | +0.83% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | Healthcare | $2.45B | 111.20 EUR | −2.63% | +15.35% |
| ATRC | AtriCure, Inc. | Healthcare | $2.45B | $48.17 | −3.43% | +21.18% |
| NUVB | Nuvation Bio Inc. | Healthcare | $2.44B | $6.96 | −28.62% | +4.04% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | Healthcare | $2.44B | 4,115.00 JPY | −14.54% | −2.00% |
| BHC | Bausch Health Companies Inc. | Healthcare | $2.43B | $6.51 | −18.63% | +44.03% |
| BHC.TO | Bausch Health Companies Inc. | Healthcare | $2.43B | 9.03 CAD | −18.50% | +41.09% |
| ONT.L | Oxford Nanopore Technologies plc | Healthcare | $2.41B | 183.00 GBP | −12.02% | +62.81% |
| KLRA | Kailera Therapeutics, Inc. | Healthcare | $2.39B | $18.44 | −34.68% | +10.16% |
| OCUL | Ocular Therapeutix, Inc. | Healthcare | $2.37B | $10.77 | −34.49% | +27.46% |
| ALMR | Alamar Biosciences, Inc. | Healthcare | $2.36B | $34.08 | −11.57% | +37.92% |
| GRDN | Guardian Pharmacy Services, Inc. | Healthcare | $2.36B | $37.48 | −20.29% | −10.46% |
| 009420.KS | Hanall Biopharma Co., Ltd. | Healthcare | $2.36B | 64,000.00 KRW | −12.33% | +53.48% |
| UFPT | UFP Technologies, Inc. | Healthcare | $2.36B | $304.57 | −10.08% | +18.02% |
| DMP.DE | Dermapharm Holding SE | Healthcare | $2.31B | 42.00 EUR | −19.08% | −1.98% |
| HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | $2.31B | $39.66 | −2.96% | +10.88% |
| BFLY | Butterfly Network, Inc. | Healthcare | $2.30B | $8.64 | −14.03% | +20.50% |
| COAG | Hemab Therapeutics Holdings, Inc. | Healthcare | $2.30B | $49.19 | −11.24% | +4.08% |
| MLYS | Mineralys Therapeutics, Inc. | Healthcare | $2.28B | $25.89 | −45.67% | −3.93% |
| NEO | NeoGenomics, Inc. | Healthcare | $2.26B | $17.37 | −0.46% | +29.63% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.